Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Fleseriu

Showing results (141-150 of 268) with videos related to

Pageof 27
Sort By:
Frontiers in Endocrinology|August 6, 2019
Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access StudyMaria Fleseriu, Chioma Iweha, Luiz Salgado, et al.
Reviews in Endocrine & Metabolic Disorders|March 15, 2025
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registriesLuigi Demarchis, Sabrina Chiloiro, Antonella Giampietro, et al.
European Journal of Endocrinology|February 25, 2025
Impact of remission status in endogenous Cushing's syndrome on cancer incidenceYaron Rudman, Maria Fleseriu, Hiba Masri-Iraqi, et al.
Journal of Endocrinological Investigation|January 28, 2025
Leukocytosis in Cushing's syndrome persists post-surgical remission and could predict a lower remission prognosis in patients with Cushing's diseaseHiba Masri-Iraqi, Yaron Rudman, Tzipora Shochat, et al.
Expert Review of Endocrinology & Metabolism|August 12, 2021
Levoketoconazole: a novel treatment for endogenous Cushing's syndromeMaria Fleseriu, Richard J Auchus, Rosario Pivonello, et al.
European Journal of Endocrinology|March 21, 2015
Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumorsIlan Shimon, Raquel S Jallad, Maria Fleseriu, et al.
Pituitary|December 21, 2011
Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?Jessica A Brzana, Chris G Yedinak, Johnny B Delashaw, et al.
Pituitary|May 20, 2024
Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with cushing's syndrome: a large population database studyLaura Dery, Julia Stern, Ilan Shimon, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 23, 2025
Cushing's syndrome related to higher rates and earlier onset of cataract: A nationwide retrospective cohort studyYael Sharon, Tzipora Shochat, Yaron Rudman, et al.
Acta Ophthalmologica|November 5, 2024
Higher risk and earlier onset glaucoma in Cushing's syndromeYael Sharon, Tzipora Shochat, Yaron Rudman, et al.
Pageof 27

Showing results (141-150 of 268) with videos related to

Sort By:
Pageof 27
Frontiers in Endocrinology|August 6, 2019
Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access StudyMaria Fleseriu, Chioma Iweha, Luiz Salgado, et al.
Reviews in Endocrine & Metabolic Disorders|March 15, 2025
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registriesLuigi Demarchis, Sabrina Chiloiro, Antonella Giampietro, et al.
European Journal of Endocrinology|February 25, 2025
Impact of remission status in endogenous Cushing's syndrome on cancer incidenceYaron Rudman, Maria Fleseriu, Hiba Masri-Iraqi, et al.
Journal of Endocrinological Investigation|January 28, 2025
Leukocytosis in Cushing's syndrome persists post-surgical remission and could predict a lower remission prognosis in patients with Cushing's diseaseHiba Masri-Iraqi, Yaron Rudman, Tzipora Shochat, et al.
Expert Review of Endocrinology & Metabolism|August 12, 2021
Levoketoconazole: a novel treatment for endogenous Cushing's syndromeMaria Fleseriu, Richard J Auchus, Rosario Pivonello, et al.
European Journal of Endocrinology|March 21, 2015
Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumorsIlan Shimon, Raquel S Jallad, Maria Fleseriu, et al.
Pituitary|December 21, 2011
Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?Jessica A Brzana, Chris G Yedinak, Johnny B Delashaw, et al.
Pituitary|May 20, 2024
Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with cushing's syndrome: a large population database studyLaura Dery, Julia Stern, Ilan Shimon, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 23, 2025
Cushing's syndrome related to higher rates and earlier onset of cataract: A nationwide retrospective cohort studyYael Sharon, Tzipora Shochat, Yaron Rudman, et al.
Acta Ophthalmologica|November 5, 2024
Higher risk and earlier onset glaucoma in Cushing's syndromeYael Sharon, Tzipora Shochat, Yaron Rudman, et al.
Pageof 27